Market Brief
China's Pharmaceutical Industry Delays, Cancels Projects Due to the COVID-19, an Industrial Info Market Brief
Although production and work have resumed in most parts of China in the wake of the COVID-19 pandemic, many pharmaceutical companies have canceled or delayed projects due to the coronavirus.
Released Friday, May 08, 2020
Although production and work have resumed in most parts of China in the wake of the COVID-19 pandemic, many
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Africa's Fertilizer Demand Sparks $5.8 Billion of ProjectsApril 28, 2021
-
Poland's PGE Plans $7 Billion Renewable Energy PushApril 28, 2021
-
Industrial Construction Activity Up 37% So Far in 2021April 26, 2021
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
Brazil Critical Minerals 2027: Rare Earths, Lithium, CopperPodcast Episode / Oct 16, 2026
-
US Craft Labor Outlook 2026: Wages, Per Diems, Data CentersPodcast Episode / Oct 16, 2026
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
